Malaria Vaccines Market, By Vaccine Type (Pre-Erythrocytic Vaccines, Erythrocytic Vaccines, and Multi-Antigen Vaccines), By Agent (Plasmodium Falciparum, Plasmodium Vivax, and Anopheles Species), By Age (Pediatric and Adult), By Distribution Channel (Public and Private), By End Users (Hospitals, Specialty Clinics, Community Health Centers, and Homecare), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Dec 2024

Code : CMI37

Pages :166

Formats :

Excel and PDF

Industry : Pharmaceutical

Regional Analysis

Malaria Vaccines Market Regional Insights

To learn more about this report, Request sample copy

North America Malaria Vaccines Market Trends

North America’s dominance in the malaria vaccines market with a share of 38.4% in 2024 can be attributed to a strong presence of major pharmaceutical companies and favorable government policies supporting research and development activities in the region. The U.S. is home to most leading vaccine manufacturers like Novavax Inc. with extensive investments in malaria vaccine development programs.

Asia Pacific Malaria Vaccines Market Trends

The Asia Pacific region exhibits the fastest growth with an estimated 27.7% share in 2024 due to rising disease burden and increasing demand for novel vaccines in highly populated countries like India and China. Substantial funding from public-private partnerships is accelerating clinical trials and vaccine access in these developing markets.

Malaria Vaccines Market Outlook for Key Countries

Central African Republic Malaria Vaccines Market Trends

The Central African Republic (CAR) plays a significant role in driving the global malaria vaccines market growth due to its high malaria incidence & R&D activities. For instance, in May 2024, the Central African Republic (CAR) introduced the R21/Matrix-M malaria vaccine into its routine Expanded Programme on Immunization (EPI), becoming the fourth country to do so after Côte d'Ivoire. The R21 vaccine, recommended by the World Health Organization, aims to reduce malaria-related deaths in endemic areas.

Brazil Malaria Vaccines Market Trends

Brazil plays a crucial role in driving the growth of the global malaria vaccines market due to its proactive approach in tackling malaria. For instance, in June 2023, Medicines for Malaria Venture (MMV) and PATH announced that Brazil has become the first malaria-endemic country to incorporate the STANDARD G6PD Test and single dose tafenoquine into its public health system for treating Plasmodium vivax (P. vivax) malaria. The Brazilian National Malaria Program, focused on malaria elimination, aims to reduce relapses and improve access to effective treatments for those affected by P. vivax malaria.

Ghana Malaria Vaccines Market Trends

Ghana has been a pioneer in malaria vaccine implementation. In April 2021, the country launched the Malaria Vaccine Implementation Programme (MVIP) in collaboration with WHO, GSK plc., a pharmaceutical company, and other partners, aiming to assess the feasibility of large-scale malaria vaccination.